Get the Stockscreener App
55.15
3.28%
1.75
Apogee Therapeutics Inc stock is traded at $55.15, with a volume of 1.04M.
It is up +3.28% in the last 24 hours and up +46.56% over the past month.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
See More
Previous Close:
$53.40
Open:
$53.43
24h Volume:
1.04M
Relative Volume:
1.58
Market Cap:
$2.54B
Revenue:
-
Net Income/Loss:
$-146.66M
P/E Ratio:
-20.02
EPS:
-2.7541
Net Cash Flow:
$-133.21M
1W Performance:
+5.11%
1M Performance:
+46.56%
6M Performance:
+66.57%
1Y Performance:
-1.92%
1-Day Range:
$52.77
$55.58
1-Week Range:
$51.51
$56.84
52-Week Range:
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
Name
Apogee Therapeutics Inc
Sector
Industry
Phone
650-394-5230
Address
221 CRESCENT ST., WALTHAM
Compare APGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
55.15 | 3.61B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-25 | Initiated | RBC Capital Mkts | Outperform |
| Jul-07-25 | Reiterated | BTIG Research | Buy |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Nov-25-24 | Initiated | Canaccord Genuity | Buy |
| May-10-24 | Initiated | BofA Securities | Buy |
| Dec-20-23 | Initiated | BTIG Research | Buy |
| Aug-08-23 | Initiated | Guggenheim | Buy |
| Aug-08-23 | Initiated | Jefferies | Buy |
| Aug-08-23 | Initiated | Stifel | Buy |
| Aug-08-23 | Initiated | TD Cowen | Outperform |
| Aug-08-23 | Initiated | Wedbush | Outperform |
View All
Apogee Therapeutics Inc Stock (APGE) Latest News
Real time scanner hits for Apogee Therapeutics Inc. explainedQuarterly Profit Review & AI Powered Market Trend Analysis - newser.com
Is it time to cut losses on Apogee Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - newser.com
Can Apogee Therapeutics Inc. stock maintain operating marginsTake Profit & Free Safe Entry Trade Signal Reports - Trung tâm Dự báo KTTV quốc gia
Using data filters to optimize entry into Apogee Therapeutics Inc.Trade Risk Summary & Daily Technical Forecast Reports - newser.com
How Apogee Therapeutics Inc. stock reacts to global recession fears2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - nchmf.gov.vn
BTIG Maintains a Buy on Apogee Therapeutics (APGE) - Insider Monkey
Will Apogee Therapeutics Inc. stock split attract more investors2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
9 Best Healthcare Stocks with the Highest Upside - Insider Monkey
How moving averages guide Apogee Therapeutics Inc. trading2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today - MSN
What indicators show strength in Apogee Therapeutics Inc.July 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsRate Hike & Low Drawdown Investment Strategies - newser.com
Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect? - sharewise.com
Best Biotech Stocks To ConsiderOctober 9th - MarketBeat
Technical signs of recovery in Apogee Therapeutics Inc.Trade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com
Apogee Therapeutics (NASDAQ:APGE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Apogee Therapeutics closes $345 million public offering By Investing.com - Investing.com Nigeria
Apogee Therapeutics, Inc. Announces Closing of Public - GlobeNewswire
Apogee Therapeutics closes $345 million public offering - Investing.com
Apogee Therapeutics Raises $345 Million From Public Offering - MarketScreener
Apogee Therapeutics Closes $345 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
$345M Raised — Apogee Therapeutics Closes Offering of 8.05M Shares Including Pre-Funded Warrants - Stock Titan
Apogee Therapeutics (NASDAQ:APGE) Given "Buy" Rating at BTIG Research - MarketBeat
What’s the recovery path for long term holders of Apogee Therapeutics Inc.Swing Trade & Weekly High Conviction Ideas - newser.com
Does Apogee Therapeutics' (APGE) $300 Million Raise Mark a Shift in Its R&D Ambition? - Yahoo Finance
Apogee Therapeutics (APGE): Assessing Valuation Following $300 Million Equity Raise - Yahoo Finance
Apogee Therapeutics: Accelerated Timelines (Again), More Money In The Bank (NASDAQ:APGE) - Seeking Alpha
Apogee Therapeutics raises $323.3 million in public offering on Nasdaq By Investing.com - Investing.com Nigeria
Apogee Therapeutics raises $323.3 million in public offering on Nasdaq - Investing.com India
Apogee Therapeutics Raises $323.3 Million in Offering - TipRanks
Apogee Therapeutics Inc Stock (APGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Apogee Therapeutics Inc Stock (APGE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer |
Oct 01 '25 |
Sale |
39.80 |
5,110 |
203,378 |
284,733 |
| Dambkowski Carl | Chief Medical Officer |
Sep 03 '25 |
Sale |
37.87 |
2,725 |
103,198 |
233,548 |
| Dambkowski Carl | Chief Medical Officer |
Aug 06 '25 |
Sale |
37.78 |
2,725 |
102,950 |
236,273 |
| Dambkowski Carl | Chief Medical Officer |
Jul 02 '25 |
Option Exercise |
22.86 |
7,365 |
168,364 |
249,088 |
| Dambkowski Carl | Chief Medical Officer |
Jul 02 '25 |
Sale |
45.09 |
10,090 |
454,954 |
238,998 |
1.84%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):